OQROSign up free
Insider trade

Relay Therapeutics (RLAY): See remarks sold ~$1.8K

Peter Rahmer, See remarks at Relay Therapeutics, sold ~$1.8K of Relay Therapeutics shares.

~$1.8K
Approx. value · 400 sh @ $4.38
390K
Holds after · shares reported
Traded
Dec 27, 2024
Filed
Dec 31, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 28, 2024Insider · 4 peopleInsiders: 5 sales (~$77K)
  2. Oct 29, 2024InsiderCFO sold ~$14K of RLAY shares in the open market
  3. Dec 16, 2024InsiderCEO sold ~$500K of RLAY shares in the open market
  4. Dec 27, 2024 · this disclosureInsiderOfficer sold ~$1.8K of RLAY shares in the open market

What came next

  1. Dec 27, 2024Insider · 3 peopleInsiders: 4 sales (~$26K)
  2. Jan 2, 2025InsiderOfficer sold ~$133K of RLAY shares in the open market
  3. Jan 3, 2025InsiderOfficer sold ~$138K of RLAY shares in the open market
  4. Jan 6, 2025InsiderOfficer sold ~$74K of RLAY shares in the open market
  5. Jan 21, 2025InsiderCEO sold ~$565K of RLAY shares in the open market
  6. Jan 22, 2025InsiderCEO sold ~$600K of RLAY shares in the open market
  7. Jan 23, 2025InsiderCEO sold ~$598K of RLAY shares in the open market
  8. Jan 28, 2025Insider · 4 peopleInsiders: 5 sales (~$345K)
  9. Jan 29, 2025Insider · 3 peopleInsiders: 3 sales (~$342K)
  10. Jan 30, 2025Insider · 4 peopleInsiders: 4 sales (~$396K)
  11. Feb 11, 2025InsiderCEO sold ~$540K of RLAY shares in the open market
  12. Feb 13, 2025InsiderCEO sold ~$279K of RLAY shares in the open market
  13. Mar 27, 2025Insider · 4 peopleInsiders: 5 sales (~$18K)
  14. Apr 23, 2025Insider · 1 personInsiders: 2 sales (~$182K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Relay Therapeutics

For Relay Therapeutics, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RLAY page.

Other recent filings by Peter Rahmer, See remarks

The full history of Peter Rahmer, See remarks is on the profile page.

How this filing works

Explore the data

Other disclosures at Relay Therapeutics

Everything OQRO holds on this company is on its RLAY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data